Advances in the treatment of indolent ly
β
Tomasz WrΓ³bel; Grzegorz Mazur
π
Article
π
2004
π
Wielkopolskie Centrum Onkologii
π
Polish
β 103 KB
Non-Hodgkin's lymphomas (nHL) are a heterogenous group of lymphoid malignancies with a different pattern of behaviour and response to treatment. In Europe and North America mainly B-cell lymphomas (86%) are observed. Indolent lymphomas are lymphoproliferative diseases with a relatively good prognosi